| 
           Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
            The web pages are not kept up to date and are for demonstration purposes only. 
            For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. 
         | 
        BACK TO LIST | 
                     
  | 
                  
                     
 
  | 
                  
                     
 
  | 
               |||||||||||||||||||||||||
| Test | 28-JAN-2025 | Reference Range | Unit | 
|---|---|---|---|
| Leukocytes [#/volume] in Blood by Automated count | 5.0 | 3.6 - 10.5 | 10*3/uL | 
| Erythrocytes [#/volume] in Blood by Automated count | 4.4 | 4.3 - 6.1 | 10*6/uL | 
| Hemoglobin [Mass/volume] in Blood | 15.6 | 13.5 - 17.5 | g/dL | 
| Hematocrit [Volume Fraction] of Blood by Automated count | 41.6 | 38 - 50 | % | 
| MCV [Entitic volume] by Automated count | 92.7 | 76 - 98 | fL | 
| MCH [Entitic mass] by Automated count | 28.9 | 27 - 33 | pg | 
| MCHC [Mass/volume] by Automated count | 33.6 | 31 - 37 | g/dL | 
| Erythrocyte distribution width [Ratio] by Automated count | 13.5 | 11.6 - 16.5 | % | 
| Platelets [#/volume] in Blood by Automated count | 180.9 | 155 - 415 | 10*3/uL | 
| Test | 28-JAN-2025 | Reference Range | Unit | 
|---|---|---|---|
| Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma | 1307.5 H | 300 - 900 | pg/mL | 
| Glucose [Mass/volume] in Serum or Plasma | 193.3 H | 70 - 140 | mg/dL | 
| Urea nitrogen [Mass/volume] in Serum or Plasma | 7.1 | 7 - 50 | mg/dL | 
| Creatinine [Mass/volume] in Serum or Plasma | 0.8 L | 0.9 - 1.3 | mg/dL | 
| Calcium [Mass/volume] in Serum or Plasma | 9.0 | 8.5 - 10.5 | mg/dL | 
| Sodium [Moles/volume] in Serum or Plasma | 140.7 | 135 - 145 | mmol/L | 
| Potassium [Moles/volume] in Serum or Plasma | 4.5 | 3.5 - 5.1 | mmol/L | 
| Chloride [Moles/volume] in Serum or Plasma | 106.3 | 98 - 108 | mmol/L | 
| Carbon dioxide, total [Moles/volume] in Serum or Plasma | 25.6 | 22 - 32 | mmol/L | 
| Protein [Mass/volume] in Serum or Plasma | 7.2 | 6 - 8.3 | g/dL | 
| Albumin [Mass/volume] in Serum or Plasma | 4.1 | 3.5 - 5.5 | g/dL | 
| Bilirubin.total [Mass/volume] in Serum or Plasma | 1.0 | 0.3 - 1.2 | mg/dL | 
| Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 58.9 | 40 - 117 | U/L | 
| Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 19.4 | 10 - 66 | U/L | 
| Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 12.4 | 10 - 40 | U/L | 
| Magnesium [Mass/volume] in Serum or Plasma | 1.8 | 1.6 - 2.6 | mg/dL | 
| Cholesterol [Mass/volume] in Serum or Plasma | 252.0 H | 0 - 200 | mg/dL | 
| Triglyceride [Mass/volume] in Serum or Plasma | 308.3 H | 0 - 199 | mg/dL | 
| Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 150.4 H | 0 - 130 | mg/dL | 
| Cholesterol in HDL [Mass/volume] in Serum or Plasma | 39.9 L | 40 - 100 | mg/dL | 
| Hemoglobin A1c/Hemoglobin.total in Blood | 5.5 | 4.5 - 6.4 | % | 
| Troponin I.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method | 0.0 | 0 - 19.9 | pg/mL | 
| Ferritin [Mass/volume] in Serum or Plasma | 136.8 | 30 - 300 | ug/L | 
| Iron [Mass/volume] in Serum or Plasma | 62.7 L | 65 - 300 | ug/dL | 
| Iron binding capacity [Mass/volume] in Serum or Plasma | 404.4 | 250 - 450 | ug/dL | 
| Iron saturation [Mass Fraction] in Serum or Plasma | 43.4 | 15 - 45 | % | 
| Conclusion and Recommendations based on this report and previous findings known to us | 
|---|
| The patient shows markedly elevated NT-proBNP, suggesting possible heart failure or cardiac strain. Glucose is high, indicating hyperglycemia, but HbA1c is within range, suggesting acute rather than chronic elevation. Lipid profile is atherogenic (high total cholesterol, LDL, triglycerides; low HDL). Creatinine is slightly low, not clinically significant. Mildly low serum iron with normal ferritin and iron saturation may reflect anemia of chronic disease or recent inflammation. Other parameters are within normal limits. Recommend clinical correlation for cardiac and metabolic risk assessment. |